MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-59-69$20.00
Mol Pharmacol 64:59-69, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diochot, S.
Right arrow Articles by Lazdunski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diochot, S.
Right arrow Articles by Lazdunski, M.

APETx1, a New Toxin from the Sea Anemone Anthopleura elegantissima, Blocks Voltage-Gated Human Ether-a-go-go–Related Gene Potassium Channels

Sylvie Diochot, Erwann Loret, Thomas Bruhn, Lászlo Béress, and Michel Lazdunski

Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique (CNRS)-Unité Mixte Recherche 6097, Valbonne, France (S.D., M.L.); Institut de Biologie Structurale et Microbiologie, CNRS Unité Propre de Recherche 9027, Marseille, France (E.L.); and the Klinikum der Christian-Albrechts-Universität, Abteilung Toxikologie, Kiel, Germany (T.B., L.B.)

A new peptide, APETx1, which specifically inhibits human ether-a-go-go–related gene (HERG) channels, was purified from venom of the sea anemone Anthopleura elegantissima. APETx1 is a 42-amino acid peptide cross-linked by three disulfide bridges and shares 54% homology with BDS-I, another sea anemone K+ channel inhibitor. Although they differ in their specific targets, circular dichroism spectra and molecular modeling indicate that APETx1 and BDS-I have a common molecular scaffold and belong to the same structural family of K+ channel blocking peptides. APETx1 inhibits HERG currents in a heterologous system with an IC50 value of 34 nM by modifying the voltage dependence of the channel gating. Central injections in mice failed to induce any neurotoxic symptoms. APETx1, which has no sequence homologies with scorpion toxins acting on HERG, defines a new structural group of HERG gating modifiers isolated from a sea anemone.


Received January 17, 2003; accepted April 7, 2003

Address correspondence to: Prof. Michel Lazdunski, Institut de Pharmacologie moléculaire et Cellulaire, CNRS- UMR6097, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France. E-mail: ipmc{at}ipmc.cnrs.fr




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Zhang, X.-S. Liu, S. Diochot, M. Lazdunski, and G.-N. Tseng
APETx1 from Sea Anemone Anthopleura elegantissima Is a Gating Modifier Peptide Toxin of the Human Ether-a-go-go- Related Potassium Channel
Mol. Pharmacol., August 1, 2007; 72(2): 259 - 268.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Restano-Cassulini, Y. V. Korolkova, S. Diochot, G. Gurrola, L. Guasti, L. D. Possani, M. Lazdunski, E. V. Grishin, A. Arcangeli, and E. Wanke
Species Diversity and Peptide Toxins Blocking Selectivity of Ether-a-go-go-Related Gene Subfamily K+ Channels in the Central Nervous System
Mol. Pharmacol., May 1, 2006; 69(5): 1673 - 1683.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics